Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Arch Pediatr ; 26(3): 133-137, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30885602

ABSTRACT

Lyme neuroborreliosis is a bacterial infection caused by the dissemination and proliferation of a Borrelia species in the central nervous system. Neuroborreliosis occurs after transmission of the pathogen from an infected tick to a human host during a tick bite. We report nine cases of pediatric neuroborreliosis collected by the National Observatory of Pediatric Bacterial Meningitis in France between 2001 and 2012. The nine children, aged 4-13 years, were identified in northern and eastern France and had the following clinical features: meningeal irritation alone or with facial palsy, or isolated facial palsy. All cases showed anti-Borrelia antibodies in cerebrospinal fluid or serum, or with a positive Borrelia PCR in the CSF. The outcome was favorable in all cases after a 2- to 3-week course of third-generation cephalosporin. On the basis of these nine pediatric cases, this study provides an update on the epidemiology, pathophysiology, diagnostic strategy, and treatment of neuroborreliosis, with insight into the specific features of pediatric neuroborreliosis and the difficulties encountered in the diagnosis of this infection.


Subject(s)
Lyme Neuroborreliosis/diagnosis , Adolescent , Amoxicillin/therapeutic use , Anti-Bacterial Agents/therapeutic use , Antibodies, Bacterial/blood , Antibodies, Bacterial/cerebrospinal fluid , Borrelia/genetics , Borrelia/immunology , Cefotaxime/therapeutic use , Ceftriaxone/therapeutic use , Child , Child, Preschool , DNA, Bacterial , Facial Paralysis/microbiology , Female , France , Humans , Lyme Neuroborreliosis/drug therapy , Male , Polymerase Chain Reaction
2.
Eur J Clin Microbiol Infect Dis ; 37(11): 2107-2115, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30094522

ABSTRACT

Intra-abdominal infections (IAIs) are one of the most common type of infections in patients with sepsis and an important cause of death in intensive care units. Early detection and treatment are necessary to reduce patient complications and improve outcomes. The Unyvero IAI Application (Curetis GmbH) is the first automated assay to rapidly and simultaneously identify a large panel of bacteria, fungi, toxins, and antibiotic resistance markers directly from IAI-related samples. The assay was evaluated in four European clinical laboratories in comparison to routine microbiological practices. A total of 300 clinical samples were tested with an overall sensitivity of 89.3% and specificity of 99.5%, while time to results was reduced by an average of about 17 h compared to identification (ID) results and 41 h compared to full antibiotic susceptibility testing (AST) results. The Unyvero IAI was able to detect additional microorganisms compared with culture, in particular anaerobes, with most detections confirmed by sequencing. The most frequent resistance markers detected were mecA/mecC (n = 25), aacA4 (n = 20), and blaCTX-M (n = 17) and carbapenemase genes were identified in nine specimens. Further studies are now required to determine the clinical impact of this new rapid test which could play a role in the successful treatment of IAI.


Subject(s)
Intraabdominal Infections/diagnosis , Intraabdominal Infections/microbiology , Microbiological Techniques , Molecular Diagnostic Techniques , Bacteria/drug effects , Bacteria/genetics , Bacterial Toxins/genetics , Diagnostic Tests, Routine , Drug Resistance, Microbial , Humans , Reproducibility of Results , Sensitivity and Specificity
3.
Antimicrob Agents Chemother ; 58(8): 4899-901, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24777104

ABSTRACT

Cefoxitin could be an alternative to carbapenems in extended-spectrum-beta-lactamase-producing Escherichia coli (ESBL-EC) infections. However, pharmacological and clinical data regarding cefoxitin are limited. Using a recent pharmacological model and the MICs of ESBL-EC collected from pyelonephritis, we determined the probabilities to reach four pharmacological targets: free cefoxitin concentrations above the MIC during 50% and 100% of the administration interval (T>MIC = 50% and T>MIC = 100%, respectively) and free cefoxitin concentrations above 4× MIC during 50% and 100% of the administration interval (T>4MIC = 50% and T>4MIC = 100%, respectively). Cefoxitin could be used to treat ESBL-EC pyelonephritis, but administration modalities should be optimized according to MICs in order to reach pharmacological targets.


Subject(s)
Anti-Bacterial Agents/pharmacology , Cefoxitin/pharmacology , Escherichia coli/drug effects , Models, Statistical , beta-Lactam Resistance , Anti-Bacterial Agents/pharmacokinetics , Carbapenems/pharmacokinetics , Carbapenems/pharmacology , Cefoxitin/pharmacokinetics , Drug Administration Schedule , Drug Dosage Calculations , Escherichia coli/enzymology , Escherichia coli/genetics , Escherichia coli/growth & development , Escherichia coli Infections/drug therapy , Escherichia coli Infections/microbiology , Gene Expression , Humans , Microbial Sensitivity Tests , Pyelonephritis/drug therapy , Pyelonephritis/microbiology , Urinary Tract Infections/drug therapy , Urinary Tract Infections/microbiology , beta-Lactamases/biosynthesis , beta-Lactamases/genetics
4.
Eur J Clin Microbiol Infect Dis ; 32(9): 1111-20, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23558364

ABSTRACT

We report on six cases of Pasteurella multocida (P. multocida) meningitis occurring between 2001 and 2011 by a French nationwide active surveillance network of paediatric bacterial meningitis (ACTIV/GPIP). The cases accounted for 0.15 % of the paediatric meningitis cases reported between 2001 and 2011 in France, all in infants <4 months old. A review of the literature allowed us to gather information on 42 other cases of P. multocida meningitis in infants <1 year old reported since 1963. Among all 48 cases, 44 % were newborns. An animal source of the infection, including 39 household dogs and cats, was suspected or identified in 42 of 48 cases. A traumatic contact between the child and a pet occurred in 8 % of cases, and a vertical transmission from mother to child during birth in 10.4 %. Most of the time, the infection resulted from non-traumatic contact between the child and the pet, through licking or sniffing. The absence of host risk factors suggests that an immature immune system is responsible, given the young age of the children. Although complications, especially neurological lesions, were not rare (37.5 %), the long-term outcome was usually good. Four infants died of meningitis. This rare disease could be prevented by reducing contact between infants and household pets, and by performing simple hygiene measures before handling babies.


Subject(s)
Meningitis, Bacterial/epidemiology , Pasteurella Infections/epidemiology , Animals , Anti-Bacterial Agents/therapeutic use , Cats , Dogs , Female , France/epidemiology , Humans , Infant , Infant, Newborn , Male , Meningitis, Bacterial/drug therapy , Meningitis, Bacterial/transmission , Pasteurella Infections/drug therapy , Pasteurella Infections/transmission , Pasteurella multocida/drug effects , Pets/microbiology
5.
J Clin Microbiol ; 50(8): 2702-7, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22692743

ABSTRACT

Matrix-associated laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) is a rapid and simple microbial identification method. Previous reports using the Biotyper system suggested that this technique requires a preliminary extraction step to identify Gram-positive rods (GPRs), a technical issue that may limit the routine use of this technique to identify pathogenic GPRs in the clinical setting. We tested the accuracy of the MALDI-TOF MS Andromas strategy to identify a set of 659 GPR isolates representing 16 bacterial genera and 72 species by the direct colony method. This bacterial collection included 40 C. diphtheriae, 13 C. pseudotuberculosis, 19 C. ulcerans, and 270 other Corynebacterium isolates, 32 L. monocytogenes and 24 other Listeria isolates, 46 Nocardia, 75 Actinomyces, 18 Actinobaculum, 11 Propionibacterium acnes, 18 Propionibacterium avidum, 30 Lactobacillus, 21 Bacillus, 2 Rhodococcus equi, 2 Erysipelothrix rhusiopathiae, and 38 other GPR isolates, all identified by reference techniques. Totals of 98.5% and 1.2% of non-Listeria GPR isolates were identified to the species or genus level, respectively. Except for L. grayi isolates that were identified to the species level, all other Listeria isolates were identified to the genus level because of highly similar spectra. These data demonstrate that rapid identification of pathogenic GPRs can be obtained without an extraction step by MALDI-TOF mass spectrometry.


Subject(s)
Bacteria, Aerobic/chemistry , Bacteria, Aerobic/classification , Bacteriological Techniques/methods , Gram-Positive Bacteria/chemistry , Gram-Positive Bacteria/classification , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Humans , Sensitivity and Specificity , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...